p.s. Some clinicians/KOLs oppose this kind of early stoppage (when it's not in their own trial, LOL) because they say it deprives them of important data. Sure. Particularly subgroup data which is helpful. But, as I am sure we agree, at some point an ethical boundary is crossed.